MRK

STRONG BUY

Merck & Co. Inc.

Health Care

0.42

PEGY ratio

Rank #14

PEGY < 0.75 — significantly undervalued relative to growth

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

PEGY Components

PEGY Score0.42

P/E Ratio15.8

EPS Growth (5yr)34.3%

Dividend Yield2.9%

Denominator37.2%

Market Data

Price$114.82

EPS (TTM)$7.28

ExchangeNYSE

S&P 500Dow 30

Analysis

MRK is trading at 15.8x earnings against 34.3% growth + 2.9% yield, giving a PEGY of 0.42. The math suggests the stock is significantly undervalued relative to its growth and income profile.

Scan date: 2026-03-18

PEGY History — 90 days

0.75 Strong Buy1.0 Buy/Hold1.5 Hold/Avoid

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only